Objective:
to identify and summarize studies examining both drug-drug interactions (DDI) and adverse drug reactions (ADR) in older adults polymedicated.
Methods:
an integrative review of studies published from January 2008 to December 2013, according to inclusion and exclusion criteria, in MEDLINE and EMBASE electronic databases were performed.
Results:
forty-seven full-text studies including 14,624,492 older adults (≥ 60 years) were analyzed: 24 (51.1%) concerning ADR, 14 (29.8%) DDI, and 9 studies (19.1%) investigating both DDI and ADR. We found a variety of methodological designs. The reviewed studies reinforced that polypharmacy is a multifactorial process, and predictors and inappropriate prescribing are associated with negative health outcomes, as increasing the frequency and types of ADRs and DDIs involving different drug classes, moreover, some studies show the most successful interventions to optimize prescribing.
Conclusions:
DDI and ADR among older adults continue to be a significant issue in the worldwide. The findings from the studies included in this integrative review, added to the previous reviews, can contribute to the improvement of advanced practices in geriatric nursing, to promote the safety of older patients in polypharmacy. However, more research is needed to elucidate gaps.
Objetivo:
identificar y resumir los estudios que analizan tanto las interacciones medicamentosas (IM) como las reacciones adversas a medicamentos (RAM) en los adultos mayores polimedicados.
MÉtodos:
revisión integradora de estudios publicados entre enero de 2008 a diciembre de 2013, siguiendo criterios de inclusión y exclusión, en las bases de datos electrónicas MEDLINE y EMBASE.
Resultados:
cuarenta y siete estudios de texto completo incluidos fueron analizados incluyendo 14,624,492 adultos mayores (≥ 60 años), de ellos 24 (51,1%) en relación con RAM, 14 (29,9%) con IM y 9 estudios (19,1%) que investigaron tanto IM como RAM. Encontramos una gran variedad de diseños metodológicos. Los estudios revisados reforzaron el concepto que la polifarmacia es un proceso multifactorial, y los predictores y la prescripción inadecuada se asocian con resultados negativos para la salud tales como el aumento de la frecuencia y tipos de RAM y IM implicando diferentes clases de fármacos, además que algunos estudios muestran cuales son las intervenciones más exitosas para optimizar la prescripción.
ConclusÕes:
IM e RAM entre idosos continuam a ser um problema significativo no mundo todo. Os resultados dos estudos incluídos nesta revisão integrativa, adicionado às revisões anteriores, podem contribuir para a melhoria das práticas avançadas de enfermagem geriátrica, para promover a segurança dos pacientes idosos em polifarmácia. No entanto, são necessárias mais pesquisas para elucidar lacunas.
Conclusiones:
IM y RAM siguen siendo un problema importante en el mundo entero entre los adultos mayores. Los resultados de los estudios incluidos en esta revisión integradora, sumado a las revisiones previas, pueden contribuir a la mejora de las prácticas avanzadas de enfermería geriátrica, para promover la seguridad de los pacientes de mayor edad en la polifarmacia. Sin embargo, se necesita más investigación para esclarecer los vacíos de conocimiento.
Citing Articles
The association between polypharmacy and disease control in rheumatoid arthritis and systemic lupus erythematosus: a cohort study.
Berthelot W, Sirois C, Julien A, Amiable N, Bessette L, Desaulniers P
Rheumatol Int. 2025; 45(3):44.
PMID: 39921727
DOI: 10.1007/s00296-025-05804-8.
Adverse Drug Reactions Among Hospitalized Psychiatric Patients, Prevalence, Severity, Preventability, and Opportunities for Intervention.
Al Hindi A, Al Balushi S, Al Ruzaiqi S, Al Busafi S, Abdulmonem S, Ali I
Oman Med J. 2024; 39(3):e631.
PMID: 39564097
PMC: 11574781.
DOI: 10.5001/omj.2024.75.
.
Chadli Z, Kasraoui K, Hannachi I, Chaabane A, Klii R, Ben Romdhane H
Tunis Med. 2024; 102(10):682-689.
PMID: 39441168
PMC: 11574366.
DOI: 10.62438/tunismed.v102i10.4970.
A Phenomenological Approach to Medication Adherence in Elderly Patients: A Qualitative Study.
Liquori G, Panattoni N, De Leo A, Dionisi S, Giannetta N, Gasperi B
Healthcare (Basel). 2024; 12(19).
PMID: 39408105
PMC: 11476112.
DOI: 10.3390/healthcare12191925.
Clinical drug interactions between voriconazole and 38 other drugs: a retrospective analysis of adverse events.
Huo B, Shu L, Xiao J, Yin N, Ai M, Jia Y
Front Pharmacol. 2024; 15:1292163.
PMID: 39403147
PMC: 11471622.
DOI: 10.3389/fphar.2024.1292163.
PHARMACOVIGILANCE IN SERBIA: A TEN-YEAR PHARMACOEPIDEMIOLOGIC ANALYSIS.
Zivanovic D, Mijatovic Jovin V, Javorac J, Samojlik I, Raskovic A, Jevtic M
Acta Clin Croat. 2024; 62(3):486-501.
PMID: 39310693
PMC: 11413999.
DOI: 10.20471/acc.2023.62.03.11.
Efficacy of therapeutic intervention with NanoBEO to manage agitation and pain in patients suffering from severe dementia: a pilot clinical trial.
Scuteri D, Pagliaro M, Mantia I, Contrada M, Pignolo L, Tonin P
Front Pharmacol. 2024; 15:1417851.
PMID: 39148533
PMC: 11325727.
DOI: 10.3389/fphar.2024.1417851.
Epidemiology of potential drug- drug interactions in hospitalized patients with type 2 diabetes mellitus in China: a retrospective study.
Ren W, Liu Y, Jiang H, Lv X, Zhang N
Front Endocrinol (Lausanne). 2024; 15:1387242.
PMID: 38982988
PMC: 11231072.
DOI: 10.3389/fendo.2024.1387242.
An Assessment of Medication Errors Among Pediatric Patients in Three Hospitals in Freetown Sierra Leone: Findings and Implications for a Low-Income Country.
Abiri O, Ninka A, Coker J, Thomas F, Smalle I, Lakoh S
Pediatric Health Med Ther. 2024; 15:145-158.
PMID: 38567243
PMC: 10986401.
DOI: 10.2147/PHMT.S451453.
Categorical Analysis of Database Consistency in Reporting Drug-Drug Interactions for Cardiovascular Diseases.
Suciu L, Ardelean S, Udrescu M, Goldis F, Handa D, Tuica M
Pharmaceutics. 2024; 16(3).
PMID: 38543232
PMC: 10975099.
DOI: 10.3390/pharmaceutics16030339.
Drug Related Problems among Older Inpatients at a Tertiary Care Setting.
Pramotesiri P, Putthipokin K, Ruangritchankul S
J Clin Med. 2024; 13(6).
PMID: 38541864
PMC: 10971276.
DOI: 10.3390/jcm13061638.
Assessment of Hemoglobin A1c Management and Prescription Cost Due to Polypharmacy Among Patients With Diabetes in Iran Based on the STEPS Iran 2016 Survey and a Prescription Database: A Multi-level, Cross-sectional National Study.
Daneshmand M, Jamshidi H, Farjoo M, Malekpour M, Ghasemi E, Mortazavi S
Arch Iran Med. 2024; 27(1):1-7.
PMID: 38431954
PMC: 10915928.
DOI: 10.34172/aim.2024.01.
The Effect of Original Russian Neurotropic Drugs on Organic Anion Transporting Polypeptides OATP1B1 and OATP1B3.
Erokhina P, Abalenikhina Y, Mylnikov P, Petrov A, Ganina S, Konyakhin E
Bull Exp Biol Med. 2024; 176(2):170-175.
PMID: 38198100
DOI: 10.1007/s10517-024-05989-1.
Assessment of potentially inappropriate medication use among geriatric outpatients in the Slovak Republic.
Kosirova S, Urbankova J, Klimas J, Foltanova T
BMC Geriatr. 2023; 23(1):567.
PMID: 37715169
PMC: 10504736.
DOI: 10.1186/s12877-023-04260-y.
Frequency, Predictors, and Outcomes of the Potential Drug-Drug Interactions in the ICUs of Teaching Hospitals in Ardabil, Northwest of Iran During 2019-2020.
Arab A, Sheikh-Germchi Z, Habibzadeh S, Sadeghiye-Ahari S, Mostafalou S
Hosp Pharm. 2023; 58(5):484-490.
PMID: 37711413
PMC: 10498974.
DOI: 10.1177/00185787231153613.
Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies.
Hamed K, Engelhardt M, Kovanda L, Huang J, Yan J, Aram J
Sci Rep. 2023; 13(1):6730.
PMID: 37185921
PMC: 10127179.
DOI: 10.1038/s41598-023-31788-1.
Symptom-specific non-pharmacological interventions for behavioural and psychological symptoms of dementia: protocol of an umbrella review of systematic reviews of randomised controlled trials.
Cho E, Kim M, Yang M, Jang J, Cho J, Lee J
BMJ Open. 2023; 13(2):e070317.
PMID: 36792326
PMC: 9933668.
DOI: 10.1136/bmjopen-2022-070317.
Efficacy of a 0.5% Propolis -0.9% Pomegranate Buccal Spray Treatment Compared with 2% Miconazole Gel for Denture Stomatitis Treatment in Elderly Patients: a Randomized Clinical Trial.
Maria Parro Y, de Mendonca Guimaraes D, Sampaio Muller H, Coelho E, Berretta A, De Lima J
J Dent (Shiraz). 2023; 23(4):472-479.
PMID: 36718161
PMC: 9883633.
DOI: 10.30476/DENTJODS.2021.91479.1588.
A combination of Beers and STOPP criteria better detects potentially inappropriate medications use among older hospitalized patients with chronic diseases and polypharmacy: a multicenter cross-sectional study.
Tang J, Wang K, Yang K, Jiang D, Fang X, Su S
BMC Geriatr. 2023; 23(1):44.
PMID: 36694126
PMC: 9875512.
DOI: 10.1186/s12877-023-03743-2.
Real-World Safety and Clinical Outcomes of Macitentan in Asian Patients with Pulmonary Arterial Hypertension: A Prospective Multicenter Study.
Jung S, Chang S, Song J, Choi J, Kim H, Choi J
Drugs Real World Outcomes. 2022; 10(1):41-49.
PMID: 36329372
PMC: 9943788.
DOI: 10.1007/s40801-022-00330-6.